Cole Hugh M
- SEC CIK
- 0001604646
No open-market purchases or sales filed in the past year.
Current role at each company
- ATXS Astria Therapeutics, Inc.Directoras of Jan 23, 2026
- JNCE Jounce Therapeutics, Inc.Chief Operating Officeras of Jan 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cole Hugh M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JNCE Jounce Therapeutics, Inc.
Chief Operating Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 (view filing) | Jan 9-10 | 2 days | Cole Hugh MChief Operating Officer | SSale | −16.6K | $1.11 | −$18.5K | −13.1%110.1K after | 2 lots |
| Jan 11, 2022 (view filing) | Jan 7-10 | 4 days | Cole Hugh MChief Business Officer | SSale | −9.67K | $6.88 | −$66.6K | −13.1%64.2K after | 2 lots |